Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Aug 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.9M
Net Open-Market Flow
-$4.9M
Transactions
10
9 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2026Option exercise(M)10K$135.42$1.3M334K
Aug 26, 2026Sell(S)559$514.64$288K333K
Aug 26, 2026Sell(S)2K$515.41$820K332K
Aug 26, 2026Sell(S)1K$516.70$583K331K
Aug 26, 2026Sell(S)4K$517.49$1.8M327K
Aug 26, 2026Sell(S)2K$518.35$928K325K
Aug 26, 2026Sell(S)476$519.35$247K325K
Aug 26, 2026Sell(S)400$520.62$208K324K
Aug 26, 2026Sell(S)40$521.48$21K324K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 26, 2026Option exercise(M)10K$056K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000129) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.